Actinogen Medical (DE:3AC)
€0.02+0.00 (+20.00%)
DE:3AC
Actinogen Medical financials statements
€0.02
At close:+0.00 (+20.00%)
Actinogen Medical (3AC) Ratios
0 Followers
Actinogen Medical Ratios
DE:3AC's free cash flow for Q4 2026 was AU$-10.45M. For the 2026 fiscal year, DE:3AC's free cash flow was decreased by AU$-6.58K and operating cash flow was AU$-10.44M. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.45 | 3.76 | 13.91 | 7.04 | 13.80 |
| Quick Ratio | 3.45 | 3.76 | 13.91 | 7.04 | 13.80 |
| Cash Ratio | 2.07 | 2.77 | 6.96 | 4.70 | 11.06 |
| Solvency Ratio | -1.83 | -2.33 | -7.82 | -5.74 | -5.81 |
| Operating Cash Flow Ratio | -2.17 | -1.27 | -12.49 | -4.83 | -6.43 |
| Short-Term Operating Cash Flow Coverage | -3.74 | -2.51 | -279.38 | -100.06 | -121.49 |
| Net Current Asset Value | AU$ 19.73M | AU$ 16.28M | AU$ 17.26M | AU$ 10.89M | AU$ 18.85M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.16 | 0.13 | 0.01 | 0.01 | 0.01 |
| Debt-to-Equity Ratio | 0.22 | 0.18 | 0.02 | 0.01 | 0.01 |
| Debt-to-Capital Ratio | 0.18 | 0.15 | 0.02 | 0.01 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.38 | 1.34 | 1.08 | 1.13 | 1.07 |
| Debt Service Coverage Ratio | -2.91 | -3.09 | -34.22 | -99.78 | -93.77 |
| Interest Coverage Ratio | -60.34 | -305.42 | -528.53 | -956.27 | -712.89 |
| Debt to Market Cap | 0.05 | 0.04 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.43 | 0.89 | 0.71 | 0.55 | 1.27 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 100.00% | 100.00% | 91.70% | 88.99% |
| EBIT Margin | 0.00% | -279.70% | -133.47% | -319.64% | -360.40% |
| EBITDA Margin | 0.00% | -272.01% | -129.28% | -311.34% | -349.40% |
| Operating Profit Margin | 0.00% | -272.01% | -129.28% | -324.74% | -361.90% |
| Pretax Profit Margin | 0.00% | -268.37% | -231.34% | -319.98% | -360.91% |
| Net Profit Margin | 0.00% | -268.37% | -131.34% | -219.98% | -260.91% |
| Continuous Operations Profit Margin | 0.00% | -168.37% | -131.34% | -219.98% | -260.91% |
| Net Income Per EBT | 54.82% | 100.00% | 56.77% | 68.75% | 72.29% |
| EBT Per EBIT | 99.79% | 98.66% | 178.95% | 98.53% | 99.73% |
| Return on Assets (ROA) | -52.03% | -60.18% | -61.21% | -70.70% | -40.75% |
| Return on Equity (ROE) | -71.96% | -80.35% | -66.23% | -80.20% | -43.69% |
| Return on Capital Employed (ROCE) | -130.99% | -80.62% | -64.34% | -118.39% | -60.35% |
| Return on Invested Capital (ROIC) | -58.92% | -43.37% | -36.31% | -80.35% | -43.32% |
| Return on Tangible Assets | -54.75% | -64.90% | -67.88% | -83.99% | -46.14% |
| Earnings Yield | -14.89% | -21.50% | -9.23% | -15.13% | -11.22% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.95 | 1.07 | 1.26 | 0.92 |
| Payables Turnover | 0.35 | 0.22 | 0.70 | 0.37 | 0.45 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 20.33 | 29.08 | 43.37 | 21.54 |
| Asset Turnover | 0.00 | 0.22 | 0.47 | 0.32 | 0.16 |
| Working Capital Turnover Ratio | 0.00 | 0.32 | 0.70 | 0.33 | 0.22 |
| Cash Conversion Cycle | -1045.71 | -1279.24 | -180.57 | -701.18 | -423.45 |
| Days of Sales Outstanding | 0.00 | 385.41 | 342.41 | 290.02 | 395.28 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 1045.71 | 1664.65 | 522.97 | 991.20 | 818.73 |
| Operating Cycle | 0.00 | 385.41 | 342.41 | 290.02 | 395.28 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.01 | -0.00 | -0.01 | -0.00 | -0.01 |
| Free Cash Flow Per Share | -0.01 | -0.00 | -0.01 | -0.00 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | -1889.80 | -198.73 | -2076.55 | -237.66 | -3240.43 |
| Capital Expenditure Coverage Ratio | -1889.80 | -198.73 | -2076.55 | -237.66 | -3240.43 |
| Operating Cash Flow Coverage Ratio | -3.67 | -2.31 | -53.13 | -100.06 | -57.59 |
| Operating Cash Flow to Sales Ratio | 0.00 | -1.38 | -1.71 | -1.78 | -2.61 |
| Free Cash Flow Yield | -17.01% | -11.08% | -12.00% | -12.29% | -11.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -6.74 | -4.69 | -10.83 | -6.61 | -8.92 |
| Price-to-Sales (P/S) Ratio | 0.00 | 12.48 | 14.23 | 14.54 | 23.26 |
| Price-to-Book (P/B) Ratio | 4.83 | 3.74 | 7.18 | 5.30 | 3.90 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.88 | -9.02 | -8.33 | -8.14 | -8.89 |
| Price-to-Operating Cash Flow Ratio | -5.88 | -9.07 | -8.34 | -8.17 | -8.90 |
| Price-to-Earnings Growth (PEG) Ratio | 1.10 | 0.26 | -2.06 | -0.88 | -0.09 |
| Enterprise Value Multiple | -3.30 | -3.70 | -10.30 | -4.12 | -5.38 |
| Enterprise Value | 91.34M | 55.29M | 132.20M | 62.70M | 68.48M |
| EV to EBITDA | -3.30 | -3.70 | -10.30 | -4.12 | -5.38 |
| EV to Sales | 0.00 | 10.07 | 13.31 | 12.83 | 18.81 |
| EV to Free Cash Flow | -5.20 | -7.28 | -7.80 | -7.18 | -7.19 |
| EV to Operating Cash Flow | -5.20 | -7.32 | -7.80 | -7.21 | -7.19 |
| Tangible Book Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Shareholders’ Equity Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.45 | 0.37 | 0.43 | 0.31 | 0.28 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
| Tax Burden | 0.55 | 1.00 | 0.57 | 0.69 | 0.72 |
| Interest Burden | 1.00 | 0.96 | 1.73 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 2.24 | 1.56 | 1.82 | 2.26 |
| SG&A to Revenue | 0.00 | 1.48 | 0.17 | 0.37 | 0.37 |
| Stock-Based Compensation to Revenue | 0.00 | 0.30 | 0.00 | 0.31 | 0.35 |
| Income Quality | 1.14 | 0.51 | 1.30 | 0.81 | 1.00 |
Currency in AUD
